Save time and get answers to complex questions with AI chat
Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Bortezomib market france?When oxcarbazepine patent expired?What is the difference between apixaban and apixaban accord?What is dabrafenib mesylate msn patent issue?
See the DrugPatentWatch profile for Symbicort
Symbicort is manufactured by AstraZeneca. The product is an inhaled medicine used for asthma and chronic obstructive pulmonary disease (COPD) and is marketed under the Symbicort brand by AstraZeneca.
The labeled manufacturer can vary by country because of regional marketing and distribution arrangements. Check the “manufacturer” or “marketing authorization holder” listed on the box and the patient information leaflet (PI/leaflet) for your specific Symbicort strength and packaging.
Symbicort (budesonide/formoterol) is associated with AstraZeneca’s intellectual property and market authorization history. For patent and exclusivity lookups by product, DrugPatentWatch.com is a useful reference point: https://www.drugpatentwatch.com/
Other Questions About Symbicort :